Natalie Sacks
2021 - Harpoon Therapeutics
In 2021, Natalie Sacks earned a total compensation of $2.7M as Former Chief Medical Officer at Harpoon Therapeutics, a 104% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $277,050 |
|---|---|
| Option Awards | $1,924,071 |
| Salary | $465,000 |
| Other | $9,741 |
| Total | $2,675,862 |
Sacks received $1.9M in option awards, accounting for 72% of the total pay in 2021.
Sacks also received $277.1K in non-equity incentive plan, $465K in salary and $9.7K in other compensation.
Rankings
In 2021, Natalie Sacks' compensation ranked 4,879th out of 12,412 executives tracked by ExecPay. In other words, Sacks earned more than 60.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,879 out of 12,412 | 61st |
Division Manufacturing | 2,040 out of 5,498 | 63rd |
Major group Chemicals And Allied Products | 862 out of 2,374 | 64th |
Industry group Drugs | 772 out of 2,095 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 195 out of 452 | 57th |
Source: SEC filing on April 27, 2023.
Sacks' colleagues
We found three more compensation records of executives who worked with Natalie Sacks at Harpoon Therapeutics in 2021.